The Lustgarten Foundation And Pancreatic Cancer Action Network Join Forces For 'Unite To Fight Pancreatic Cancer', A First Of Its Kind Walk Event In Boston
BOSTON, Mass., April 9, 2013 /PRNewswire/ -- The Lustgarten Foundation and the Pancreatic Cancer Action Network are proud to announce that they will join forces and efforts for Unite to Fight Pancreatic Cancer, a special walk event scheduled to take place in Boston at DCR's Mother's Rest Park on Saturday, September 28, 2013.
This is a first of its kind event, bringing together the two leading organizations in the fight against pancreatic cancer. By joining forces for the event, the two organizations hope to create more awareness and raise more funds in the fight against this deadly disease. Registration for the Unite to Fight Pancreatic Cancer walk is now open.
"Pancreatic cancer is the fourth leading cause of cancer death in the United States and is estimated to become the second leading cause of death by the year 2020, possibly as early as 2015. Now more than ever, it's critical that the pancreatic cancer community comes together to fight this disease as one," said Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network. "We are thrilled to partner with The Lustgarten Foundation on Unite to Fight Pancreatic Cancer and look forward to a successful event."
Kerri Kaplan, executive director of The Lustgarten Foundation, said, "We are proud to join with the Pancreatic Cancer Action Network for this walk event. We both are determined to raise more awareness and funds to fight this deadly disease. Research is the way toward early detection, better treatments, and ultimately, a cure. We hope the Boston community will join us in September in that spirit of hope."It is estimated that more than 45,000 Americans will be diagnosed with pancreatic cancer this year. Proceeds from the Unite to Fight Pancreatic Cancer walk event will support each organization's respective missions. To learn more about the event, go to www.unite2fightpc.org. About the Pancreatic Cancer Action Network Founded in 1999, the Pancreatic Cancer Action Network is a nationwide network of people dedicated to working together to advance research, support patients and create hope for those affected by pancreatic cancer. The Pancreatic Cancer Action Network takes a comprehensive approach to fighting the disease, focusing on research, patient services, community outreach, and advocacy. The organization has helped to build a robust pancreatic cancer scientific community through its research grants program, recently helped to pass the Recalcitrant Cancer Research Act, has served more than 70,000 individuals through its Patient and Liaison Services program, and has an active volunteer presence in more than 90 communities across the country. About The Lustgarten Foundation The Lustgarten Foundation is America's largest private funder of pancreatic cancer research. Based in Bethpage, New York, the Foundation supports research to find a cure for pancreatic cancer, facilitates dialogue within the medical and scientific community, and educates the public about the disease through awareness campaigns and fundraising events. The Foundation has provided millions of research dollars and assembled the best scientific minds with the hope that one day, a cure can be found. Cablevision Systems Corporation, a leading media and telecommunications company, underwrites all of The Lustgarten Foundation's administrative costs, so that 100 percent of every dollar donated to the Foundation goes directly to pancreatic cancer research. Learn more at www.curePC.org. Both The Lustgarten Foundation and the Pancreatic Cancer Action Network have been awarded the highest 4-star rating for fiscal responsibility from Charity Navigator, America's largest and most utilized independent evaluator of charities.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts